On Thursday, the U.S. Department of Health and Human Services (HHS) announced its final ruling on changes to Medicare Part D regarding cancer patients’ access to lifesaving drugs. In the final ruling, HHS ruled that Part D plans will not be able to deny coverage for the newest cancer drugs